See who made this year's Rising Stars list—and how you can attend the summit.
MORE►
Phronetik
Form Bio, named as one of eight Rising Stars to be honored at iC3 2023, announced its launch at the last year's summit. [Photo: John Davidson/Form Bio]
BioNTX iC3 Summit to Fuel North Texas Life Science Ecosystem, Honor 8 Rising Stars
by Quincy Preston | Sep 14, 2023
The North Texas bioscience organization, a driving force for growth in the regional ecosystem, will convene leaders at its flagship conference to catalyze industry opportunities, spotlight emerging companies, and make connections.
See who made this year's Rising Stars list—and how you can attend the summit.
See who made this year's Rising Stars list—and how you can attend the summit.
Related Articles
The Last Word: On Lyda Hill Philanthropies’ Redesigned ‘IF/THEN’ Website
Is Your Organization Ready for AI? Key Considerations to Assess AI Readiness
The Last Word: On the World’s First ‘Biolumenescent’ Flower, Going on Sale Friday at Calloway’s
The Last Word: On Sam’...
The Last Word: On the Dallas Holocaust and Human Rights Museum Honoring Holocaust Remembrance Day
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
